Patents
Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
03/2000
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
02/2000
02/24/2000WO2000009509A2 Process for the large-scale synthesis of 4,10-dinitro -2,6,8,12- tetraoxa- 4,10-diazatetracyclo- [5.5.0.0?5,903,11¿]- dodecane
02/16/2000EP0979227A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
02/09/2000CN1244196A 3-amino-1,2-benzoisoxazole derivatives, process for preparation,a nd use thereof
02/02/2000EP0975622A1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
01/2000
01/26/2000EP0973730A1 Calcilytic compounds
01/19/2000CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors
01/19/2000CN1048484C A process for preparing a composition containing benzoheterocycles
01/06/2000CA2330110A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
01/05/2000CN1240429A The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
01/04/2000US6011045 Inhibitors of bone resorption; anticancer agents
12/1999
12/29/1999WO1999067219A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
12/29/1999CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999CA2324474A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/28/1999US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis
12/16/1999WO1999064406A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999CA2333551A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
11/1999
11/24/1999CN1236363A Process for production of 4-substituted-3-halogeno-1, 4-benzoxazepine derivative and salts thereof
11/23/1999US5990145 Antiinflammatory,-carcinogenic,-tumor,-metastasis agents; cardiovascular disorders, e.g., arteriosclerosis, restenosis; retinopaathies and nephropathies; osteoporosis
11/16/1999US5985869 Benzoheterocyclic compounds
11/10/1999CN1234795A Heterocyclic esters and amides chemical compounds
10/1999
10/27/1999EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/26/1999US5973188 Anticoagulant; prevention cell, protein binding
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/19/1999US5968478 N- methyl piperazine compounds having dopamine receptor affinity
10/13/1999CN1231661A Aralkyl and aralkylidene heterocyclic lactams and imides
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/06/1999EP0946180A1 Method for stimulating bone formation
09/1999
09/29/1999EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
09/14/1999US5952320 Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
09/02/1999WO1999043670A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
09/02/1999CA2321830A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
09/01/1999EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/1999
08/17/1999US5939412 Bicyclic fibrinogen antagonists
08/11/1999EP0934287A1 Heterocyclic esters and amides
07/1999
07/27/1999US5929097 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/27/1999US5929069 Compounds activating pharmacological effects of retinoids
07/21/1999EP0929528A1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/21/1999CN1044237C 4,1-benzoxazep in derivatives and their use
06/1999
06/30/1999EP0925288A1 Process of production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof
06/30/1999CN1221409A Bibenzo-oxazepine and dioxepine derivatives and their use as anti-tumor agents
06/22/1999US5914332 Retroviral protease inhibiting compounds
06/16/1999EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
06/09/1999EP0920423A1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
04/1999
04/28/1999EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
04/28/1999CN1215054A Bychclic fibrinogen antagonists
04/22/1999WO1999011624B1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
04/07/1999EP0906907A1 Compounds potentiating retinoid
04/07/1999EP0906295A1 Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents
03/1999
03/31/1999EP0773778B1 Hair styling composition and method
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/23/1999US5885979 Squalene synthetase inhibitor treating or preventing hyperlipidemia
03/11/1999WO1999011635A1 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2(3h)-ones useful as hiv reverse transcriptase inhibitors
03/11/1999WO1999011626A1 Integrin receptor antagonists
03/11/1999WO1999011624A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999CA2304117A1 Integrin receptor antagonists
03/11/1999CA2303295A1 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2(3h)-ones useful as hiv reverse transcriptase inhibitors
03/11/1999CA2294118A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/02/1999US5877170 Substitute caprolactams and derivatives thereof useful for treatment of HIV disease
02/1999
02/17/1999CN1208405A Retroviral protease inhibiting compounds
02/11/1999WO1999006049A1 Integrin receptor antagonists
02/11/1999CA2298544A1 Integrin receptor antagonists
02/09/1999US5869483 Tricyclic benzazepine vasopressin antagonists
02/04/1999WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same
02/03/1999EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
02/03/1999CN1041921C Bicyclic fibrinogen antagonists
01/1999
01/28/1999WO1999003847A1 Process of production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof
01/12/1999US5859239 Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepines and benzothiazepines
01/05/1999US5856477 Hypotensive agents; congestive heart failure
01/05/1999US5856476 Processes for preparing azepiones useful as intermediates in the preparation of inhibitors of angiotensin converting enzyme and neutral endopeptidase
12/1998
12/29/1998US5854274 Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives
12/29/1998US5854236 Tricyclic benzazepine vasopressin antagonists
12/16/1998CN1202161A Macrocyclic compounds as metalloprotease inhibitors
12/16/1998CN1202160A Compounds potentiating retinoid
12/15/1998US5849735 Tricyclic benzazepine vasopressin antagonists
12/09/1998EP0882024A1 Retroviral protease inhibiting compounds
12/09/1998EP0632803B1 Arthropodicidal amides
12/08/1998US5846969 Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/01/1998US5843952 Tricyclic benzazepine vasopressin antagonists
11/1998
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998DE19720798A1 Preparation of cyclic or polymeric compounds by selective olefin metathesis of poly:unsaturated substrate
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/10/1998US5834462 Antitumor agents; anticarcinogenic agents particularly for nasopharyngel, pulmonary, intestinal, mammary, uterus, gastric, ovarian or liver cancer and also leukemia
11/10/1998US5834459 Treatment of schizophrenia, nervous system disorders
11/03/1998US5830890 Fungicidal acrylate derivatives
10/1998
10/29/1998WO1998047891A1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
10/29/1998WO1998047882A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
10/29/1998CA2285664A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
10/20/1998US5824676 Piperazinyl-dibenz(b,f)(1,4)oxazepine derivatives
10/15/1998WO1998045255A1 Calcilytic compounds
10/15/1998CA2286454A1 Calcilytic compounds
10/14/1998CN1196052A Benzoxazepine compounds, their production method and use
10/08/1998WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21